Gene Therapy in X-linked Retinitis Pigmentosa Due to Defects in RPGR

Int Ophthalmol Clin. 2021 Oct 1;61(4):97-108. doi: 10.1097/IIO.0000000000000384.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Eye Proteins / genetics
  • Genetic Therapy
  • Humans
  • Retinitis Pigmentosa* / genetics
  • Retinitis Pigmentosa* / therapy

Substances

  • Eye Proteins
  • RPGR protein, human